LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDY

Jemal, 2004, Cancer statistics, 2004, CA Cancer J Clin, 54, 8, 10.3322/canjclin.54.1.8 D'Hallewin, 2002, Fluorescence detection of bladder cancer: a review, Eur Urol, 42, 417, 10.1016/S0302-2838(02)00402-5 Lopatkin, 2000, Fluorescent diagnostics of urinary bladder cancer, Urologiia, 4, 3 Jichlinski, 2003, Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for photodiagnosis of superficial bladder cancer—a multicenter study, J Urol, 170, 226, 10.1097/01.ju.0000060782.52358.04 Kriegmair, 1996, Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence, J Urol, 155, 105, 10.1016/S0022-5347(01)66559-5 Filbeck, 1999, Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid, J Endourol, 13, 117, 10.1089/end.1999.13.117 Koenig, 1999, Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid, BJU Int, 83, 129, 10.1046/j.1464-410x.1999.00917.x Al'-Shukri, 2000, ALA fluorescent diagnosis of bladder cancer, Urologiia, 5, 48 Schmidbauer, 2004, Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy, J Urol, 171, 135, 10.1097/01.ju.0000100480.70769.0e Riedl, 1999, Fluorescence detection of bladder tumors with 5-amino-levulinic acid, J Endourol, 13, 755, 10.1089/end.1999.13.755 Miller, 1998, Leitlinien zur Diagnostik und Therapie des Harnblasenkarzinoms, Urologe A, 37, 440, 10.1007/s001200050205 Soloway, 2003, Editorial: Bladder cancer. How can we make a difference?, J Urol, 170, 1781, 10.1097/01.ju.0000092149.02524.65 Riedl, 2001, Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer, J Urol, 165, 1121, 10.1016/S0022-5347(05)66442-7 Klän, 1991, Residual tumor discovered in routine second transurethral resection in patients with stage T transitional cell carcinoma of the bladder, J Urol, 146, 316, 10.1016/S0022-5347(17)37779-0 Köhrmann, 1994, The value of secondary transurethral resection for superficial bladder tumors, Akt Urol, 25, 208, 10.1055/s-2008-1058226 Filbeck, 2003, Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study, Urologe A, 42, 1366, 10.1007/s00120-003-0355-y Grimm, 2003, Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study, J Urol, 170, 433, 10.1097/01.ju.0000070437.14275.e0 Babjuk, 2004, 5-Aminolevulinic acid induced fluorescence cystoscopy reduces the risk of early recurrence after transurethral resection of superficial bladder tumours. Results of prospective randomized trial, Eur Urol, suppl, 45, 124, 10.1016/S1569-9056(04)90484-8 Rassweiler, 2000, Fluorescence aided transurethral resection of superficial bladder cancer. Does it improve the quality of TUR?, Eur Urol, suppl., 37, 110 Zaak, 2001, Decrease of early recurrence by means of 5-aminolevulinic acid-induced fluorescence endoscopy in patients with bladder cancer - follow up of a randomized phase-III-trial, J Urol, suppl, 165 Gomella, 2004, The use of Hexvix and fluorescence cystoscopy as an adjunct in the diagnosis of carcinoma in situ of the urinary bladder, J Urol, 171, 69, 10.1016/S0022-5347(18)37526-8 Grossman, 2004, The use of Hexvix and fluorescence cystoscopy as an adjunct in the diagnosis of stage TA/T1 urothelial cancer in the urinary bladder, J Urol, 171, 69, 10.1016/S0022-5347(18)37525-6